General information about company

Name of The CompanyTATVA CHINTAN PHARMA CHEM LIMITED
BSE Scrip Code543321
NSE SymbolTATVA
MSE SymbolNOTLISTED
Date of Start of Financial Year01-04-2023
Date of End of Financial Year31-03-2024
Reporting PeriodSecond half yearly
Date of Start of Reporting Period01-10-2023
Date of End of Reporting Period31-03-2024
Level of rounding to be used in disclosing related party transactionsMillions
Whether the company has any related party?Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?Yes



(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/publicNA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.NA
(III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)?No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.






Related party transactions

Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Sr No.Details of the party (listed entity /subsidiary) entering into the transactionDetails of the counterpartyType of related party transactionDetails of other related party transactionValue of the related party transaction as approved by the audit committeeRemarks on approval by audit committeeValue of transaction during the reporting periodIn case monies are due to either party as a result of the transactionIn case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investmentsDetails of the loans, inter-corporate deposits, advances or investmentsNotes
NamePANNamePANRelationship of the counterparty with the listed entity or its subsidiaryOpening balanceClosing balanceNature of indebtedness (loan/ issuance of debt/ any other etc.)Details of other indebtednessCostTenureNature (loan/ advance/ intercorporate deposit/ investment )Interest Rate (%)TenureSecured/ unsecuredPurpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1Tatva Chintan Pharma Chem LimitedAABCT0623NTatva Chintan USA Inc.ZZZZZ9999ZWholly owned SubsidiarySale of goods or services2000Approved228.9855.1859.44Textual Information(1)
2Tatva Chintan Pharma Chem LimitedAABCT0623NTatva Chintan USA Inc.ZZZZZ9999ZWholly owned SubsidiaryInvestmentNot Applicable06.666.66Textual Information(2)
3Tatva Chintan Pharma Chem LimitedAABCT0623NTatva Chintan Europe B.V.ZZZZZ9999ZWholly owned SubsidiarySale of goods or services2000Approved231.4453.77185.71Textual Information(3)
4Tatva Chintan Pharma Chem LimitedAABCT0623NTatva Chintan Europe B.V.ZZZZZ9999ZWholly owned SubsidiaryInvestmentNot Applicable00.010.01Textual Information(4)
5Tatva Chintan Pharma Chem LimitedAABCT0623NChintan Nitinkumar ShahAGQPS0271DPromoter - Chairman and Managing DirectorRemunerationNot Applicable5.140.760Textual Information(5)
6Tatva Chintan Pharma Chem LimitedAABCT0623NChintan Nitinkumar ShahAGQPS0271DPromoter - Chairman and Managing DirectorAny other transactionReimbursement of office expensesNot Applicable0.0200Textual Information(6)
7Tatva Chintan Pharma Chem LimitedAABCT0623NAjaykumar Mansukhlal PatelACSPP6803CPromoter - Wholetime DirectorRemunerationNot Applicable5.140.760Textual Information(7)
8Tatva Chintan Pharma Chem LimitedAABCT0623NShekhar Rasiklal SomaniAKRPS2524APromoter - Wholetime DirectorRemunerationNot Applicable5.140.760Textual Information(8)
9Tatva Chintan Pharma Chem LimitedAABCT0623NShekhar Rasiklal SomaniAKRPS2524APromoter - Wholetime DirectorAny other transactionReimbursement of office expensesNot Applicable0.280.020.02Textual Information(9)
10Tatva Chintan Pharma Chem LimitedAABCT0623NAshok BothraAGFPB9662EChief Financial OfficerRemunerationNot Applicable3.20.280.23Textual Information(10)
11Tatva Chintan Pharma Chem LimitedAABCT0623NIshwar NayiAPGPN4130HCompany Secretary and Compliance OfficerRemunerationNot Applicable0.620.080.09Textual Information(11)
12Tatva Chintan Pharma Chem LimitedAABCT0623NManher Chimanlal DesaiABTPD1932ENon-Executive Independent DirectorAny other transactionSitting feesNot Applicable0.1100Textual Information(12)
13Tatva Chintan Pharma Chem LimitedAABCT0623NSubhash Ambubhai PatelADFPP1273NNon-Executive Independent DirectorAny other transactionSitting feesNot Applicable0.1200Textual Information(13)
14Tatva Chintan Pharma Chem LimitedAABCT0623NAvani Rajesh UmattAAHPU9204BNon-Executive Independent DirectorAny other transactionSitting feesNot Applicable0.0900Textual Information(14)
15Tatva Chintan Pharma Chem LimitedAABCT0623NShah Shimoni ChintanEGYPS5156MRelative of Key Managerial PersonnelRemunerationNot Applicable0.180.020.02Textual Information(15)
16Tatva Chintan Pharma Chem LimitedAABCT0623NAryan Shekhar SomaniNDHPS3925PRelative of Key Managerial PersonnelRemunerationNot Applicable0.170.020.02Textual Information(16)
Total value of transaction during the reporting period480.63